Abdelmalek MF, Diehl AM (2007) Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am 91:1125–1149

Article  CAS  PubMed  Google Scholar 

Amemiya-Kudo M, Shimano H, Hasty AH et al (2002) Transcriptional activities of nuclear SREBP-1a, −1c, and −2 to different target promoters of lipogenic and cholesterogenic genes. J Lipid Res 43:1220–1235

CAS  PubMed  Google Scholar 

Anderson N, Borlak J (2008) Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev 60:311–357

Article  CAS  PubMed  Google Scholar 

Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911–917

Article  CAS  PubMed  Google Scholar 

Brunt EM, Janney CG, Di Bisceglie AM et al (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467–2474

Article  CAS  PubMed  Google Scholar 

Burk O, Tegude H, Koch I et al (2002) Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. J Biol Chem 277:24280–24288

Article  CAS  PubMed  Google Scholar 

Cheung O, Puri P, Eicken C et al (2008) Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression. Hepatology 48:1810–1820

Article  PubMed Central  CAS  PubMed  Google Scholar 

Cui JY, Gunewardena SS, Rockwell CE, Klaassen CD (2010) ChIPing the cistrome of PXR in mouse liver. Nucleic Acids Res 38:7943–7963

Article  PubMed Central  CAS  PubMed  Google Scholar 

Dai G, He L, Bu P, Wan YJ (2008) Pregnane X receptor is essential for normal progression of liver regeneration. Hepatology 47:1277–1287

Article  CAS  PubMed  Google Scholar 

Dif N, Euthine V, Gonnet E et al (2006) Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem J 400:179–188

Article  PubMed Central  CAS  PubMed  Google Scholar 

Donnelly KL, Smith CI, Schwarzenberg SJ et al (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343–1351

Article  PubMed Central  CAS  PubMed  Google Scholar 

Farese RV, Walther TC (2009) Lipid droplets finally get a little R-E-S-P-E-C-T. Cell 139:855–860

Article  PubMed Central  CAS  PubMed  Google Scholar 

Fernández-Alvarez A, Tur G, López-Rodas G, Casado M (2008) Reciprocal regulation of the human sterol regulatory element binding protein (SREBP)-1a promoter by Sp1 and EGR-1 transcription factors. FEBS Lett 582:177–184

Article  PubMed  Google Scholar 

Geick A, Eichelbaum M, Burk O (2001) Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampicin. J Biol Chem 276:14581–14587

Article  CAS  PubMed  Google Scholar 

George J, Liddle C (2008) Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets. Mol Pharm 5:49–59

Article  CAS  PubMed  Google Scholar 

Ghose R, Omoluabi O, Gandhi A et al (2011) Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters. Life Sci 89:57–64

Article  PubMed Central  CAS  PubMed  Google Scholar 

Hawkins JL, Robbins MD, Warren LC et al (2008) Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals. J Pharmacol Exp Ther 326:801–808

Article  CAS  PubMed  Google Scholar 

He J, Gao J, Xu M et al (2013) PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice. Diabetes 62:1876–1887

Article  PubMed Central  CAS  PubMed  Google Scholar 

Hoffart E, Ghebreghiorghis L, Nussler AK et al (2012) Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor. Br J Pharmacol 165:1595–1608

Article  PubMed Central  CAS  PubMed  Google Scholar 

Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125–1131

Article  PubMed Central  CAS  PubMed  Google Scholar 

Joshi A, Rajput S, Wang C et al (2010) Murine aldo–keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10. Biol Chem 391:1371–1378

Article  CAS  PubMed  Google Scholar 

Khogali AM, Chazan BI, Metcalf VJ, Ramsay JH (1974) Hyperlipidaemia as a complication of rifampicin treatment. Tubercle 55:231–233

Article  CAS  PubMed  Google Scholar 

Kodama S, Negishi M (2013) PXR cross-talks with internal and external signals in physiological and pathophysiological responses. Drug Metab Rev 45:300–310

Article  CAS  PubMed  Google Scholar 

Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ (2014) Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146:726–735

Article  CAS  PubMed  Google Scholar 

Li ZZ, Berk M, McIntyre TM, Feldstein AE (2009) Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem 284:5637–5644

Article  PubMed Central  CAS  PubMed  Google Scholar 

Ma J, Yan R, Zu X et al (2008) Aldo–keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells. J Biol Chem 283:3418–3423

Article  CAS  PubMed  Google Scholar 

Moreau A, Téruel C, Beylot M et al (2009) A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte. Hepatology 49:2068–2079

Article  CAS  PubMed  Google Scholar 

Nakamura K, Moore R, Negishi M, Sueyoshi T (2007) Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver. J Biol Chem 282:9768–9776

Article  PubMed Central  CAS  PubMed  Google Scholar 

Nies AT, Koepsell H, Winter S et al (2009) Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology 50:1227–1240

Article  CAS  PubMed  Google Scholar 

Nussler AK, Nussler NC, Merk V et al (2009) The holy grail of hepatocyte culturing and therapeutic use. In: Santin M (ed) Strategies in regenerative medicine. Springer, New York, pp 283–320

Google Scholar 

Pascussi JM, Robert A, Nguyen M et al (2005) Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 115:177–186

Article  PubMed Central  CAS  PubMed  Google Scholar 

Reed BD, Charos AE, Szekely AM et al (2008) Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet 4:e1000133

Article  PubMed Central  PubMed  Google Scholar 

Rysä J, Buler M, Savolainen MJ et al (2013) Pregnane X receptor agonists impair postprandial glucose tolerance. Clin Pharmacol Ther 93:556–563

Article  PubMed  Google Scholar 

Sanyal AJ (2005) Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2:46–53

Article  CAS  PubMed  Google Scholar 

Shimomura I, Shimano H, Horton JD et al (1997) Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 99:838–845

Article  PubMed Central  CAS  PubMed  Google Scholar 

Sookoian S, Castaño GO, Burgueño AL et al (2010) The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease. Pharmacogenet Genomics 20:1–8

Article  CAS  PubMed  Google Scholar 

Spruiell K, Richardson RM, Cullen JM et al (2014) Role of pregnane X receptor in obesity and glucose homeostasis in male mice. J Biol Chem 289:3244–3261

Article  PubMed Central  CAS  PubMed  Google Scholar 

Starmann J, Fälth M, Spindelböck W et al (2012) Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis. PLoS One 7:e46584

Article  PubMed Central  CAS  PubMed  Google Scholar 

Sundqvist A, Bengoechea-Alonso MT, Ye X et al (2005) Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab 1:379–391

Article  CAS  PubMed  Google Scholar 

Takagi S, Nakajima M, Mohri T, Yokoi T (2008) Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 283:9674–9680

Article  CAS  PubMed  Google Scholar 

Tolson AH, Wang H (2010) Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev 62:1238–1249

Article  PubMed Central  CAS  PubMed  Google Scholar 

Trauner M, Halilbasic E (2011) Nuclear receptors as new perspective for the management of liver diseases. Gastroenterology 140:1120–1125

Article  CAS  PubMed  Google Scholar 

Tsuzura H, Genda T, Sato S et al (2014) Expression of aldo–keto reductase family 1 member B10 in the early stages of human hepatocarcinogenesis. Int J Mol Sci 15:6556–6568

Article  PubMed Central  CAS  PubMed  Google Scholar 

Wagner M, Zollner G, Trauner M (2011) Nuclear receptors in liver disease. Hepatology 53:1023–1034

Article  CAS  PubMed  Google Scholar 

Wang C, Yan R, Luo D et al (2009) Aldo–keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls. J Biol Chem 284:26742–26748

Article  PubMed Central  CAS  PubMed  Google Scholar 

Zhou J, Zhai Y, Mu Y et al (2006) A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J Biol Chem 281:15013–15020

Article  PubMed Central  CAS  PubMed  Google Scholar 

Zhou C, Poulton EJ, Grün F et al (2007) The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Pharmacol 71:220–229

Article  CAS  PubMed  Google Scholar